Sponsored by the American Society of Hematology, American College of Obstetricians and Gynecologists, and Association of Maternal & Child Health Programs.

October 28, 2021| 2:00 p.m.

Barriers to receiving high quality, comprehensive care for sickle cell disease (SCD) are a significant problem in the United States, resulting in health care disparities and inequities. This is especially true for women with SCD who are pregnant: they are ten times more likely to die in childbirth than non-Hispanic Black women without SCD. This disparity is compounded by the fact that the maternal mortality rate for all non-Hispanic Black women is already more than double the U.S. maternal mortality rate. Women with SCD require high-quality, multidisciplinary reproductive health care; their deaths are not inevitable. Comprehensive care is proven to decrease the risk of adverse pregnancy outcomes, including maternal mortality.

Cosponsored by the American Society of Hematology, American College of Obstetricians and Gynecologists, Association of Maternal & Child Health Programs, and Sickle Cell Disease Association of America, this briefing will present an overview about the current state of reproductive health care for women with SCD, a personal story of a mother’s pregnancy journey with the disease; and a presentation of proposed policy strategies to improve the outcomes. Join us to learn how you can help improve SCD care and outcomes for women with SCD. Click here for more details about the program and to register.